ViGeneron Rebrands as VeonGen Therapeutics, Accelerates Clinical Pipeline in IRDs
VeonGen Therapeutics debuts with FDA recognition and bold plans for inherited eye diseases. ViGeneron (Munich, Germany) announced its rebranding as…
FDA Grants Rare Pediatric Disease Designation to Ocugen’s Gene Therapy for Stargardt Disease
Ocugen’s OCU410ST gene therapy lands a rare badge of honor in the fight against IRDs. The U.S. Food and Drug…
popular posts
latest posts
![[Internal] Newsroom Researchers Develop Head Mounted Robotic System for Retinal Surgery (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/02/Internal-Newsroom-Researchers-Develop-Head-Mounted-Robotic-System-for-Retinal-Surgery-1-579x326.png)